Quick10K

⚲

Rich Pharmaceuticals

Filings

10-K	2018-03-31	Filed 2018-07-17
S-1	2018-01-24	Public Filing
10-Q	2017-12-31	Filed 2018-02-20
10-Q	2017-09-30	Filed 2017-12-29
10-Q	2017-06-30	Filed 2017-12-06
10-K	2017-03-31	Filed 2017-09-05
10-Q	2016-12-31	Filed 2017-02-13
10-Q	2016-09-30	Filed 2016-11-21
10-Q	2016-06-30	Filed 2016-08-22
10-K	2016-03-31	Filed 2016-08-22
10-Q	2015-12-31	Filed 2016-02-22
10-Q	2015-09-30	Filed 2015-11-23
10-Q	2015-06-30	Filed 2015-09-25
10-K	2015-03-31	Filed 2015-09-17
10-Q	2014-12-31	Filed 2015-02-23
10-Q	2014-09-30	Filed 2014-11-19
10-Q	2014-06-30	Filed 2014-08-19
10-K	2014-03-31	Filed 2014-07-15
10-Q	2013-12-31	Filed 2014-02-19
10-Q	2013-09-30	Filed 2013-11-19
10-Q	2013-06-30	Filed 2013-08-19
10-K	2013-03-31	Filed 2013-07-01
10-Q	2012-06-30	Filed 2012-08-13
10-K	2012-03-31	Filed 2012-07-11
10-Q	2011-12-31	Filed 2012-03-09

Reports

8-K	2019-06-11
8-K	2019-02-12
8-K	2018-04-10
8-K	2018-03-15
8-K	2018-03-02
8-K	2018-02-09
8-K	2018-02-01
8-K	2018-01-18
8-K	2018-01-10
8-K	2018-01-02

Rich Pharmaceuticals Financials

RCHA Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin


Comps ($'000 TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
US Stem Cell (USRM)	0	58%	-0.2	-481%	656	9,770	2,763	1,598	-3,158	-2,256	378
Bravatek Solutions (BVTK)	0	73%	0.0	-158%	151	8,437	199	146	-239	-114	-2
Visium Technologies (VISM)	0		0.0	-31,116%	3	3,141	0	0	-796	-796	-3
Fiverr (FVRR)
Zenergy Brands (ZNGY)	0	17%	0.0	-171%	2,124	8,074	2,085	345	-3,635	-3,635	-6
Patriot Scientific (PTSC)	0		1.2	-41%	1,925	228	0	0	-798	-797	-986
Granite Real Estate (GRP)
Growlife (PHOT)	0	33%	0.0	-130%	4,626	9,064	6,744	2,193	-6,029	-4,695	-201
Dais Analytic (DLYT)	0	36%	0.0	-597%	414	8,700	1,055	378	-2,470	-2,184	-14
Jumia (JMIA)
Rich Pharmaceuticals (RCHA)	0	-6%	0.0	-4,521%	37	6,396	115	-7	-1,692	-2,356	-6
InMode (INMD)
View Systems (VSYM)	0	100%	-0.8	-1,148%	27	1,083	1	1	-308	-272	226
Owl Rock Capital (ORCC)
Endonovo Therapeutics (ENDV)	0	73%	-0.8	-301%	3,414	19,980	204	150	-10,268	-9,617	7,448
Link Motion (LKM)	0			0%	853,628	377,864	0	0	0	0	-91,397
Cerence (CRNC)
W&E Source (WESC)	0	100%	0.0	-419%	14	182	1	1	-60	-60	-3
Ford Motor Credit (FMCC)	0	0%	15.7	1%	160,883,000	146,728,000	12,691,000	0	2,313,000	7,242,000	114,027,000
Sirva (SRVA)


Balance Sheet ($'000)	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31
Cash	30	12	12	12	4	2	60	10	18	12	0	4	6	16	0	0	3	0	0	0	0	41	4	25	4	6
Accounts Receivable
Inventory
PP&E									1	1	1	1	1	1	1	1	1	4	3	3	2	2	2	2	1	1
Assets	30	12	12	12	4	2	60	84	48	15	103	6	89	24	6	3	5	7	6	3	2	53	21	57	35	37
Accounts Payable										181	248	170	183	910	916	911	981	1,139	1,155	351	367	350	350	312	352	327
Long-Term Debt										38	133
Liabilities	0	11	13	15	17	31	97	210	213	853	618	1,025	1,216	1,743	1,763	1,912	2,578	2,398	2,518	2,761	3,208	5,379	7,530	5,363	5,246	6,396
Stockholders' Equity	30	2	-0	-2	-13	-29	-37	-126	-166	-837	-515	-1,018	-1,127	-1,719	-1,757	-1,909	-2,573	-2,392	-2,512	-2,758	-3,205	-5,326	-7,509	-5,306	-5,211	-6,359


Income Statement ($'000)	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31
Revenue	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	115	0	0
Cost of Revenue											80	81	8	32	6	0	4	6	10	6	10	19	5	95	22
Gross Profit											-80	-81	-8	-32	-6	0	-4	-6	-10	-6	-10	-19	-5	20	-22
R&D															7	2	0	8	0	0	0	72	148	148	93	91
SG&A	0	0	0	0	0	0	0
Tax		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Income		-28	-2	-2	-11	-16	-8	-124	-190		-520	-671	-1,436	-1,506	-648	-309	-901	89	-178	-267	-540	-2,256	-2,302	1,796	55	-1,242


Cash Flow ($'000)	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31
Cash Operating		-21	-1	-4	-14	-13	-6	-165	-91	-81	-352	-398	-284	-411	-142	-89	-112	-152	-132	-58	-98	-264	-176	-118	-76	-139
Cash Investing									-1	-23			0	0			-1	-3				-10	-5	-15	0	3
Cash Financing			1	4	5	11	64	137	100	98	340	402	286	421	126	89	116	151	132	58	98	315	144	154	55	138